News Announcement

Vivanza Biosciences: Financial Results For 31-12-2018

Considered and approved the Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter ended December 31 2018 along with Limited Review Report thereon dropped decision of change of Registrar and Share Transfer Agent of the Company and adopted policies pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations 2018 (w.e.f. April 01 2019).

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds